- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Oncxerna Therapeutics Inc.
Headquarters: Waltham, MA, United States of America
Website: https://oncxerna.com/
Year Founded: 2018
Status: Private
BioCentury | Oct 5, 2022
Management Tracks
Owkin finds new CBO in Sanofi SVP
Plus CEO Séjourné moves to Aurobac and updates from Quantum, BioHaven and more
BioCentury | Aug 18, 2021
Management Tracks
Smith named CEO at Remix
Plus: Jubilant, Sparrow, n-Lorem, OncXerna and more
BioCentury | Jun 15, 2021
Management Tracks
Avila joins Atea as SVP of medical affairs; plus Werewolf, Senda, Aurion, Sigilon and more
Viral infections company Atea Pharmaceuticals Inc. (NASDAQ:AVIR) hired Claudio Avila as SVP of medical affairs. Avila joins from Gilead Sciences Inc. (NASDAQ:GILD), where he was executive director of
BioCentury | Jan 29, 2021
Management Tracks
Bilenker leaving Lilly’s Loxo; plus updates from Orchard, Genfit, OncXerna, Medable, Neurophth, Elevian, Biofidelity, BIO
Josh Bilenker is leaving Eli Lilly and Co. (NYSE:LLY) as CEO of Loxo Oncology to explore other opportunities, Lilly CSO and SVP Daniel Skovronsky said during the pharma’s 4Q20 earnings
BioCentury | Aug 12, 2019
Company News
Aug. 12 Company Quick Takes: Jazz buying Cavion; plus Boehringer, AC Immune, Oncologie
BioCentury | Jun 10, 2019
Finance
$80M series B backs Oncologie's biomarkers, which could give new life to old therapies
Chinese VCs return to lead Oncologie's $80M series B, which will help the company reach the clinic and grow its pipeline
Items per page:
1 - 10 of 10